vTv Therapeutics Inc.

03/18/2021 | Press release | Distributed by Public on 03/18/2021 14:09

vTv Therapeutics Announces Initiation of Study Evaluating TTP399’s Potential to Reduce Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes